This content is in French.
Lymphoma & the heart: a long-term debt?
15 septembre 2025
By Ana Espino | Published on september 15, 2025 | 3 min read
#Lymphoma #Cardiotoxicity #Cardiology
Lymphomas, although largely curable thanks to advances in treatment, expose patients to a significant risk of late cardiac toxicity, particularly after administration of anthracyclines and mediastinal radiotherapy. These side effects may appear years after remission, with long-lasting impact on survivors’ quality of life and cardiovascular morbidity.
#Lymphoma #Cardiotoxicity #Cardiology
Lymphomas, although largely curable thanks to advances in treatment, expose patients to a significant risk of late cardiac toxicity, particularly after administration of anthracyclines and mediastinal radiotherapy. These side effects may appear years after remission, with long-lasting impact on survivors’ quality of life and cardiovascular morbidity.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Nygård, L., et al. (2025). Late Cardiac Toxicity After Anthracyclines and Radiotherapy for Lymphoma-A Regression Analysis of Dose-Response. Hematological oncology, 43(5), e70134
View the source
